FDA Monthly Preview: Key April Decisions to Watch - Top-Institutions - MDSpire

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

  • By

  • Kathryn Wighton

  • March 31, 2026

  • 3 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Nephrology
    • Endocrinology
    • Infectious Diseases

  • #2

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Infectious Diseases
    • Endocrinology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Nephrology
    • Endocrinology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Infectious Diseases
    • Endocrinology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Nephrology
    • Endocrinology
    • Infectious Diseases

Original Source(s)

FDA Monthly Preview: Key April Decisions to Watch

  • by Kathryn Wighton

  • March 31, 2026

Related Content

Endovascular thrombectomy in patients with acute ischemic stroke and prestroke mRS 3: a multicenter IPTW analysis focused on functional preservation

A systemic review of facial expression recognition (FER) in stroke: diagnosis and emerging applications in rehabilitation

Effects of trampoline training on lower-limb strength and balance in children and adolescents with special needs: a multilevel systematic review and meta-analysis